Overview of Using Flow Cytometry for Developing Better Lead Candidates
To maximize the chances that a therapeutic candidate is successful in clinical trials, rapid and accurate lead identification and characterization are critical. Traditional screening assays are limited in their ability to replicate and measure biological context and can often measure only one parameter at a time. With its flexilbity, throughput, ability to measure multiple parameters simultaneously, and compatibility with live cells, flow cytometry can solve these challenges and is growing in popularity for lead candidate screening.
Read this article to learn about:
- How flow cytometry facilitates cell-based primary screens, preserving biological context for drug activity
- Why the ability to measure multiple parameters matters for both primary and secondary screens
- What to look for when selecting a flow cytometer for your lead candidate screening needs
Download the Article
Share a little information with us to access the entire article now.
Thank you for your interest in ! Access the article here.View Article
Content you'll also find interesting
Thank you for submitting the form.